Expert insights. Personalized for you.
The pharma is the first to seek emergency approval for this kind of treatment, and may quickly follow up with a second request after reporting promising data for a two-drug combination MORE
This translates to longer development times for cancer drugs which means that cancer patients could suffer. It’s essential that drug companies get creative and find new ways to reach patients when incomes to cancer drug screening and clinical trials. MORE
The unusual startup already has partial rights to multiple drugs developed by MyoKardia and affiliates of BridgeBio, and plans to acquire many more MORE
University of New Mexico researchers find existing medications may fight coronavirus infection University of New Mexico researchers who combed through a “library” of previously approved drugs believe they have identified a medication with the potential to help speed a patient’s recovery from SARS-CoV-2 infection. “The gist of it is we think we found a drug […]. MORE
He and his colleagues recently published a cancer drug atlas that predicts synergistic combination therapies for cancer. Asked what triggered the idea of a cancer drug atlas, Bart starts with a question he’s asked by cancer clinicians: “I have this patient who is not reacting to therapy. MORE
online pharmacy that actually tests the quality of medication it sends to patients and apparently, to my delight, they support drug importation as a policy to lower costs. Food and Drug Administration to make sure those drugs will work as directed by their prescribers. MORE
The trial would be the first test of a systemically administered gene editing treatment that uses the Nobel Prize-winning technology to alter DNA MORE
Prescription Justice has graded all members of Congress in a drug prices report card. 3, the Elijah Cummings Lower Drug Costs Now Act, through the House and vociferously called for its passage on the House floor, as read on the Speaker’s website. Drug Prices MORE
There’s a lot of talk on PharmacyCheckerBlog about Big Pharma doing this and Big Pharma doing that to keep drug prices high in America. This week, we at Prescription Justice announced the new Congressional Report Card on Drug Prices. Drug PricesCongress is on my mind this week. MORE
The biotech's KRAS-blocking pill trails Amgen's sotorasib in development, but early data suggest it might match the bar set by Amgen MORE
QUICK READ : Prescribers are reviewing some of their favorite prescribed drugs and are open to learning about new drugs in terms of efficacy and patient outcomes but you had better be ready to talk about patients beyond the science. MORE
A weaker-than-expected benefit for omecamtiv mecarbil, a key drug the companies are developing for heart failure, raised doubts about the medicine's potential role MORE
An 18-month investigation by the House Oversight Committee targeted the pricing practices behind the top-selling drugs Revlimid and Copaxone MORE
Pharma CEO’s serve themselves with big salaries tied to drug prices and keeping drugs from coming off patent. On Wednesday, three pharmaceutical executives, including former Celgene CEO Mark Alles, testified on drug pricing for the House Oversight Committee. MORE
Together, the companies expect to make three and a half times as many doses of Regeneron's antibody drug than the U.S. biotech could on its own MORE
The licensing deal hands AbbVie exclusive rights to a drug that targets CD47, a protein which has caught the attention of other large drugmakers like Gilead and Celgene MORE
Negative results for the experimental drug semorinemab dents a theory that Alzheimer's disease may be caused by tangles of the protein tau in the brain MORE
Kevzara failed to shorten hospital stays among patients severely sick with COVID-19, study results showed, further dimming hopes that drugs similar to it could help combat the disease MORE
DNA-encoded libraries (DELs) have been gaining a lot of traction in hit finding and drug discovery in recent years. Vertex Pharmaceuticals has paired up with X-Chem in order to utilize their DELs for drug discovery. MORE
Research for the drug, now cleared as Inmazeb, helped Regeneron jumpstart its fast development of an antibody therapy for COVID-19 MORE
New results from an WHO study, however, raise questions about the drug's ultimate effectiveness The U.S. regulator granted a full approval after allowing emergency use earlier this year. MORE
may be hard to follow, since venture investors and big pharma acquirers have largely ignored cardiovascular drugs Recent deals for MyoKardia and The Medicines Co. MORE
University of Delaware researchers advance drug delivery systems to treat connective tissue disorders Credit: Graphic illustration by Jeffrey C. MORE
Newly published data show that, after joining a clinical trial, patients who were given a drug from Amylyx Pharmaceutcials lived a median 6.5 months longer than those who didn't MORE
Merck's deal for Seattle Genetics' antibody-drug conjugate comes as Gilead agreed to acquire rival developer Immunomedics in the biotech industry's largest buyout of 2020 MORE
The results, from a mid-stage study of Lilly's drug, suggest treatment helped lower virus levels, but the degree to which patients benefited remains unclear MORE
The New Jersey facility that ran afoul of FDA manufacturing standards is one of several Lilly is using to produce coronavirus antibody drugs MORE
In most cases, the reason is that the same drugs sold in the U.S. million Americans import drugs to save money each year. First, wholesale importation of lower cost drugs from Canada is now lawful. That is pursuant to Section 804 of the Food, Drug and Cosmetic Act. MORE
With BioMarin's gene therapy sidelined, attention is turning to other drugs, including one Sanofi acquired when it paid $11.6 billion for Bioverativ MORE
Drugs Related Topics World of DTC Marketing
OCTOBER 6, 2020
This translates to longer development times for cancer drugs which means that cancer patients could suffer. It’s essential that drug companies get creative and find new ways to reach patients when incomes to cancer drug screening and clinical trials.
Bio Pharma Dive
OCTOBER 22, 2020
New results from an WHO study, however, raise questions about the drug's ultimate effectiveness The U.S. regulator granted a full approval after allowing emergency use earlier this year.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
JULY 23, 2020
QUICK READ : Prescribers are reviewing some of their favorite prescribed drugs and are open to learning about new drugs in terms of efficacy and patient outcomes but you had better be ready to talk about patients beyond the science.
Pharmacy Checkers
SEPTEMBER 10, 2020
online pharmacy that actually tests the quality of medication it sends to patients and apparently, to my delight, they support drug importation as a policy to lower costs. Food and Drug Administration to make sure those drugs will work as directed by their prescribers.
Bio Pharma Dive
OCTOBER 14, 2020
Research for the drug, now cleared as Inmazeb, helped Regeneron jumpstart its fast development of an antibody therapy for COVID-19
Bio Pharma Dive
SEPTEMBER 29, 2020
Meanwhile, the drug has also caught the attention of a powerful cost watchdog group On Nov. 6, aducanumab will go before a panel of experts who will review it and make recommendations to the FDA.
Bio Pharma Dive
OCTOBER 8, 2020
may be hard to follow, since venture investors and big pharma acquirers have largely ignored cardiovascular drugs Recent deals for MyoKardia and The Medicines Co.
Bio Pharma Dive
OCTOBER 16, 2020
Newly published data show that, after joining a clinical trial, patients who were given a drug from Amylyx Pharmaceutcials lived a median 6.5 months longer than those who didn't
Bio Pharma Dive
AUGUST 31, 2020
Debunking myths around working with the FDA for oncology drug approval
Bio Pharma Dive
AUGUST 26, 2020
Founders of Dutch biotech Dezima have created NewAmsterdam Pharma and bought back the cholesterol drug they sold to Amgen in 2015
Bio Pharma Dive
OCTOBER 7, 2020
The pharma is the first to seek emergency approval for this kind of treatment, and may quickly follow up with a second request after reporting promising data for a two-drug combination
Bio Pharma Dive
OCTOBER 13, 2020
Despite the setback, the biotech still sees a path forward for its drug in asthma and plans to find a partner to move it into further testing
Bio Pharma Dive
SEPTEMBER 16, 2020
The results, from a mid-stage study of Lilly's drug, suggest treatment helped lower virus levels, but the degree to which patients benefited remains unclear
Bio Pharma Dive
OCTOBER 8, 2020
A weaker-than-expected benefit for omecamtiv mecarbil, a key drug the companies are developing for heart failure, raised doubts about the medicine's potential role
Pharma R&D Today
AUGUST 6, 2020
He and his colleagues recently published a cancer drug atlas that predicts synergistic combination therapies for cancer. Asked what triggered the idea of a cancer drug atlas, Bart starts with a question he’s asked by cancer clinicians: “I have this patient who is not reacting to therapy.
Bio Pharma Dive
OCTOBER 22, 2020
The New Jersey facility that ran afoul of FDA manufacturing standards is one of several Lilly is using to produce coronavirus antibody drugs
Bio Pharma Dive
OCTOBER 1, 2020
An 18-month investigation by the House Oversight Committee targeted the pricing practices behind the top-selling drugs Revlimid and Copaxone
Bio Pharma Dive
SEPTEMBER 10, 2020
With BioMarin's gene therapy sidelined, attention is turning to other drugs, including one Sanofi acquired when it paid $11.6 billion for Bioverativ
Bio Pharma Dive
OCTOBER 19, 2020
The trial would be the first test of a systemically administered gene editing treatment that uses the Nobel Prize-winning technology to alter DNA
Pharma R&D Today
OCTOBER 7, 2020
DNA-encoded libraries (DELs) have been gaining a lot of traction in hit finding and drug discovery in recent years. Vertex Pharmaceuticals has paired up with X-Chem in order to utilize their DELs for drug discovery.
Scienmag
OCTOBER 16, 2020
University of New Mexico researchers find existing medications may fight coronavirus infection University of New Mexico researchers who combed through a “library” of previously approved drugs believe they have identified a medication with the potential to help speed a patient’s recovery from SARS-CoV-2 infection. “The gist of it is we think we found a drug […].
Bio Pharma Dive
AUGUST 19, 2020
Together, the companies expect to make three and a half times as many doses of Regeneron's antibody drug than the U.S. biotech could on its own
World of DTC Marketing
OCTOBER 1, 2020
Pharma CEO’s serve themselves with big salaries tied to drug prices and keeping drugs from coming off patent. On Wednesday, three pharmaceutical executives, including former Celgene CEO Mark Alles, testified on drug pricing for the House Oversight Committee.
Bio Pharma Dive
SEPTEMBER 2, 2020
Democratic lawmakers have been unhappy with AbbVie's response to an ongoing drug pricing probe, and are now demanding the drugmaker turn over more information
Pharmacy Checkers
OCTOBER 21, 2020
The highest score in the Prescription Justice Congressional Report Card on Drug Prices – 100 – goes to Representative Jan Schakowsky (D-IL) , with a grade of A+. If all members of Congress hopped on the drug price lowering bandwagon just like Rep. Drug Prices
Bio Pharma Dive
SEPTEMBER 4, 2020
The licensing deal hands AbbVie exclusive rights to a drug that targets CD47, a protein which has caught the attention of other large drugmakers like Gilead and Celgene
Bio Pharma Dive
OCTOBER 16, 2020
The results could weaken the case for widely using Veklury, also known as remdesivir, just as the company is asking for full approval from the FDA
Bio Pharma Dive
OCTOBER 26, 2020
The biotech's KRAS-blocking pill trails Amgen's sotorasib in development, but early data suggest it might match the bar set by Amgen
Bio Pharma Dive
SEPTEMBER 22, 2020
Study data show Blueprint's first approved cancer drug, Ayvakit, could also work to treat a rare disease, a result that sent the company's shares higher
Bio Pharma Dive
SEPTEMBER 1, 2020
Kevzara failed to shorten hospital stays among patients severely sick with COVID-19, study results showed, further dimming hopes that drugs similar to it could help combat the disease
Bio Pharma Dive
AUGUST 11, 2020
The unusual startup already has partial rights to multiple drugs developed by MyoKardia and affiliates of BridgeBio, and plans to acquire many more
Bio Pharma Dive
SEPTEMBER 8, 2020
Partners Blueprint and Roche will now compete with Eli Lilly and its rival drug Retevmo Gavreto is cleared to treat certain lung cancer patients who have so-called RET mutations.
Bio Pharma Dive
AUGUST 7, 2020
The agency's decision kicks off a historic and dramatic regulatory review, as significant lingering questions surround aducanumab's approval chances
Scienmag
OCTOBER 8, 2020
University of Delaware researchers advance drug delivery systems to treat connective tissue disorders Credit: Graphic illustration by Jeffrey C.
Bio Pharma Dive
SEPTEMBER 14, 2020
Merck's deal for Seattle Genetics' antibody-drug conjugate comes as Gilead agreed to acquire rival developer Immunomedics in the biotech industry's largest buyout of 2020
Pharmacy Checkers
AUGUST 7, 2020
There’s a lot of talk on PharmacyCheckerBlog about Big Pharma doing this and Big Pharma doing that to keep drug prices high in America. This week, we at Prescription Justice announced the new Congressional Report Card on Drug Prices. Drug PricesCongress is on my mind this week.
Bio Pharma Dive
SEPTEMBER 8, 2020
Merck's drug could be the first-ever treatment for chronic cough, a condition that afflicts millions. But side effects and modest efficacy may limit its use
Bio Pharma Dive
AUGUST 7, 2020
Approval of Evrysdi, from Roche and PTC Therapeutics, adds a third option for treating the neuromuscular disease, joining Spinraza and Zolgensma
Pharmacy Checkers
SEPTEMBER 18, 2020
Prescription Justice has graded all members of Congress in a drug prices report card. 3, the Elijah Cummings Lower Drug Costs Now Act, through the House and vociferously called for its passage on the House floor, as read on the Speaker’s website. Drug Prices
Pharmacy Checkers
OCTOBER 2, 2020
In most cases, the reason is that the same drugs sold in the U.S. million Americans import drugs to save money each year. First, wholesale importation of lower cost drugs from Canada is now lawful. That is pursuant to Section 804 of the Food, Drug and Cosmetic Act.
232 
Let's personalize your content